(Press-News.org) LOS ANGELES -- A new study from Keck Medicine of USC has uncovered significant racial disparities in the diagnosis, treatment and outcomes of peripheral artery disease (PAD) among Black and white patients in the United States.
PAD, which affects approximately eight to 12 million Americans and is associated with nearly half of the 150,000 yearly amputations in the U.S., is a potentially life-threatening condition in which the arteries that carry blood from the heart to the legs narrow or become blocked by the buildup of fatty plaque. This can lead to a heart attack, stroke or amputation of the affected limb.
“We discovered that Black patients are nearly 50% less likely to receive vascular interventions to potentially restore the blood flow than white patients, and consequently are at a disproportionately higher risk of a stroke, heart attack or amputation,” said David Armstrong, DPM, PhD, a podiatric surgeon specializing in limb preservation with Keck Medicine and an author of the study. “Additionally, Black patients tend to have more advanced PAD and are sicker at the time of diagnosis, indicating they may not be getting as timely medical attention as their white counterparts.”
PAD often starts out with no or mild symptoms, such as a leg cramp or muscle pain, and therefore often goes underdiagnosed.
Once detected, generally through a blood test, PAD is typically treated with medication to reduce the plaque in the arteries and through suggested lifestyle changes, such as increased exercise and a healthy diet. If these measures don’t work, physicians usually recommend a procedure known as revascularization. Revascularization either improves the blood flow to the arteries by using a balloon or stent to open them or reroutes the blood to another, healthier artery, which can reduce the risk of a cardiac incident or amputation.
The study discovered that Black patients are more likely to only receive medication and lifestyle change recommendations, while white patients also receive revascularization. “Our findings suggest Black patients are missing out on potentially limb- and life-saving treatments,” said Armstrong. “And because Black patients tend to be sicker at the time of diagnosis than white patients, they may actually be in more need of a revascularization than other patients.”
Armstrong and his colleagues used a large national database to compare rates of diagnostic testing, treatment patterns and outcomes after diagnosis of PAD among commercially insured patients in the United States from the years 2016 to 2021. They identified some 455,000 white patients and 96,000 Black patients. They then compared demographics, markers of disease severity and health care costs as well as patterns of medical management and rates of amputation and cardiovascular events among the two patient groups to reach their conclusions.
While the study did not analyze why disparities in the detection, treatment and outcomes of PAD between Black and white patients exist, one factor may be that Black patients are already at a higher risk of developing PAD, said Armstrong. He also hypothesizes that the inequalities may be due to broader systematic issues in health care such as unconscious bias or barriers to health care access for certain populations.
“We hope this study will encourage physicians to take these differences into account when diagnosing and treating PAD to ensure that vascular interventions are being equally provided to all patients,” he said. “We also urge health professionals to offer more routine screenings for PAD in Black patients.”
Additionally, Armstrong advises patients to proactively seek medical advice and testing if they have any symptoms related to PAD — leg cramping, pain, numbness, weakness or discoloration — and advocate to be considered for all treatment options after diagnosis.
###
For more information about Keck Medicine of USC, please visit news.KeckMedicine.org.
END
Black patients with plaque build-up in arteries in the legs more likely to have a stroke, heart attack or amputation than white patients
New study shows Black patients are nearly 50% less likely to receive vascular interventions that could potentially avoid adverse outcomes
2023-06-13
ELSE PRESS RELEASES FROM THIS DATE:
Estimating dementia risk using multifactorial prediction models
2023-06-13
About The Study: The findings of this study suggest that current dementia risk scores have limited clinical utility for estimation of 10-year dementia risk. Further research is needed to develop more accurate algorithms for estimation of dementia risk.
Authors: Mika Kivimäki, Ph.D. of University College London, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi: 10.1001/jamanetworkopen.2023.18132)
Editor’s Note: Please see the article for ...
Content analysis of emoji and emoticon use in clinical texting systems
2023-06-13
About The Study: This study found that when clinicians use emoji and emoticons in secure clinical texting systems, these symbols function primarily to convey new and interactionally salient information. These results suggest that concerns about the professionalism of emoji and emoticon use may be unwarranted.
Authors: Colin M. E. Halverson, Ph.D., of the Indiana University School of Medicine in Indianapolis, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi: 10.1001/jamanetworkopen.2023.18140)
Editor’s Note: Please ...
People who preserve ‘immune resilience’ live longer, resist infections
2023-06-13
Embargoed by Nature Communications until 10 a.m. Central Time on Tuesday, June 13
SAN ANTONIO (June 13, 2023) — Researchers from The University of Texas Health Science Center at San Antonio, working with collaborators in five countries, today revealed that the capacity to resist or recover from infections and other sources of inflammatory stress — called “immune resilience” — differs widely among individuals. The researchers developed a unique set of metrics to quantify the level ...
Improving potential stem cell-based treatments for patients with Type 1 Diabetes
2023-06-13
Following encouraging results from pre-clinical research and a recent clinical trial on stem cell-based treatments for patients with Type 1 diabetes, researchers are now working on maximizing the function and potential of stem cell-based treatments for future application in patients.
More than 8 billion people worldwide live with Type 1 diabetes (T1D) according to recent estimates. In T1D, the so-called beta cells in the pancreas do not make enough of the hormone insulin due to the destruction of beta-cells by the immune system leading to blood sugar levels rising above normal levels. Over time, T1D can lead to severe organ damage. There is no cure ...
Lung and heart stem cell research paves way for new COVID-19 treatments
2023-06-13
Researchers have used heart and lung stem cells infected with the virus that causes COVID-19 to better understand how the disease impacts different organs, paving the way for more targeted treatments.
The research, co-led by Murdoch Children’s Research Institute and the Peter Doherty Institute for Infection and Immunity (Doherty Institute), found the responses to SARS-CoV-2 varied significantly depending on the cell type, allowing the team to identify effective anti-viral drugs to treat infection in heart and lung cells. The findings were published in the 10th anniversary edition of Stem Cell Reports.
Murdoch ...
Four state policies linked to growth of telehealth at mental health facilities
2023-06-13
Four state policies introduced during the COVID-19 pandemic to spur expansion of telehealth were associated with expansion of such services by mental health facilities, but growth of telehealth was lower among facilities in counties with the greatest proportion of Black residents, according to a new RAND Corporation study.
Expansion of telehealth also was lower among facilities that accepted Medicaid or the Children’s Health Insurance Program, two government insurance programs that aid primarily lower-income Americans, according to the study.
The findings show that disparities in access to mental health care persisted even as ...
Only 1 in 4 adolescent treatment facilities offer buprenorphine for opioid use disorder
2023-06-13
Only 1 in 4 residential addiction treatment facilities caring for U.S. adolescents under 18 years old offer buprenorphine, a medication used to treat opioid use disorder, according to a new study. Only 1 in 8 offer buprenorphine for ongoing treatment. These findings highlight a significant gap in access to evidence-based addiction treatment among young people. Published in JAMA, this study was supported by the National Institute on Drug Abuse (NIDA) and the National Center for Advancing Translational Sciences ...
Mapping the development of infection-fighting immune cells
2023-06-13
LA JOLLA (June 13, 2023)—The immune system protects the body from invaders, such as bacteria, viruses, or tumors, with its intricate network of proteins, cells, and organs. Specialized immune cells, called cytotoxic T cells, can develop into short-lived effector cells that kill infected or cancerous cells within our bodies. A small portion of those effector cells remain after an infection and become longer-lived memory cells, which “remember” infections and respond when infections reappear. ...
Pew funds 22 scientists exploring pressing biomedical questions
2023-06-13
PHILADELPHIA—The Pew Charitable Trusts today announced the 22 researchers selected to join the Pew Scholars Program in the Biomedical Sciences. These early-career scientists will receive four years of funding to spearhead innovative studies exploring human health and medicine.
“From vaccine development to treatments for complex diseases, biomedical research is foundational to solving some of the world’s greatest health challenges,” said Susan K. Urahn, Pew’s president and CEO. “Pew is thrilled to welcome this new class of researchers and support their efforts to advance scientific knowledge and improve human ...
5 Pew-Stewart Scholars selected to advance cutting-edge cancer research
2023-06-13
PHILADEPHIA—The Pew Charitable Trusts and the Alexander and Margaret Stewart Trust announced today the 2023 class of the Pew-Stewart Scholars Program for Cancer Research.
These early-career scientists will receive four-year grants to explore new horizons in cancer development, diagnosis, and treatment. This class marks the 10th year the Alexander and Margaret Stewart Trust has partnered with Pew to build a legacy of innovative cancer research.
“Cancer is one of the most pressing challenges facing biomedical researchers today,” said Susan K. Urahn, Pew’s president and CEO. “Pew ...
LAST 30 PRESS RELEASES:
CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injury
Melatonin receptor 1a alleviates sleep fragmentation-aggravated testicular injury in T2DM by suppression of TAB1/TAK1 complex through FGFR1
Single-cell RNA sequencing reveals Shen-Bai-Jie-Du decoction retards colorectal tumorigenesis by regulating the TMEM131–TNF signaling pathway-mediated differentiation of immunosuppressive dendritic ce
Acta Pharmaceutica Sinica B Volume 15, Issue 7 Publishes
New research expands laser technology
Targeted radiation offers promise in patients with metastasized small cell lung cancer to the brain
A high clinically translatable strategy to anti-aging using hyaluronic acid and silk fibroin co-crosslinked hydrogels as dermal regenerative fillers
Mount Sinai researchers uncover differences in how males and females change their mind when reflecting on past mistakes
CTE and normal aging are difficult to distinguish, new study finds
Molecular arms race: How the genome defends itself against internal enemies
Tiny chip speeds up antibody mapping for faster vaccine design
KTU experts reveal why cultural heritage is important for community unity
More misfolded proteins than previously known may contribute to Alzheimer’s and dementia
“Too much going on”: Autistic adults overwhelmed by non-verbal social cues
What’s driving America’s deep freezes in a warming world?
A key role of brain protein in learning and memory is deciphered by scientists
Heart attacks don’t follow a Hollywood script
Erin M. Schuman wins 2026 Nakasone Award for discovery on neural synapse function and change during formation of memories
Global ocean analysis could replace costly in-situ sound speed profiles in seafloor positioning, study finds
Power in numbers: Small group professional coaching reduces rates of physician burnout by nearly 30%
Carbon capture, utilization, and storage: A comprehensive review of CCUS-EOR
New high-temperature stable dispersed particle gel for enhanced profile control in CCUS applications
State gun laws and firearm-related homicides and suicides
Use of tobacco and cannabis following state-level cannabis legalization
Long-term obesity and biological aging in young adults
Eindhoven University of Technology and JMIR Publications announce unlimited open access publishing agreement
Orphan nuclear receptors in metabolic dysfunction-associated steatotic liver disease development
A technological breakthrough for ultra-fast and greener AI
Pusan National University researchers identify key barriers hindering data-driven smart manufacturing adoption
Inking heterometallic nanosheets: A scalable breakthrough for coating, electronics, and electrocatalyst applications
[Press-News.org] Black patients with plaque build-up in arteries in the legs more likely to have a stroke, heart attack or amputation than white patientsNew study shows Black patients are nearly 50% less likely to receive vascular interventions that could potentially avoid adverse outcomes